Weleader Biomedical Co (ROCO:7713) Change In Inventory: NT$-5 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7713 Weleader Biomedical Co Ltd ROCO:7713
69 GF Score
Price NT$73.90
GF Value NT$74.38
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Weleader Biomedical Co Change In Inventory?

Weleader Biomedical Co ROCO:7713 -0.14% 69 Change In Inventory is NT$-5 Mil as of Jun. 2026. GuruFocus rates ROCO:7713 with a GF Score™ of 69/100 and a GF Value™ of NT$74.38 (Fairly Valued). The stock has 5 warning signs investors should review.

Weleader Biomedical Co's change in inventory for the quarter that ended in Jun. 2026 was NT$3 Mil. It means Weleader Biomedical Co's inventory declined by NT$3 Mil from Mar. 2026 to Jun. 2026 .

Weleader Biomedical Co's change in inventory for the fiscal year that ended in Dec. 2025 was NT$-19 Mil. It means Weleader Biomedical Co's inventory increased by NT$19 Mil from Dec. 2024 to Dec. 2025 .

Weleader Biomedical Co's Total Inventories for the quarter that ended in Jun. 2026 was NT$130 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Weleader Biomedical Co's Days Inventory for the quarter that ended in Jun. 2026 was 55.64.

Inventory Turnover measures how fast the company turns over its inventory within a year. Weleader Biomedical Co's Inventory Turnover for the quarter that ended in Jun. 2026 was 1.64.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Weleader Biomedical Co's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.39.


Weleader Biomedical Co  (ROCO:7713) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Weleader Biomedical Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=131.5155/215.668*365 / 4
=55.64

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Weleader Biomedical Co's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Weleader Biomedical Co's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Weleader Biomedical Co Change In Inventory Related Terms


Weleader Biomedical Co Change In Inventory Historical Data

* Premium members only.

The historical data trend for Weleader Biomedical Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Weleader Biomedical Co Change In Inventory Chart

Weleader Biomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial -13.37 -7.10 -5.77 -29.81 -18.78

Weleader Biomedical Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.36 -1.28 8.83 -15.55 2.60
ROCO:7713
69GF Score
Weleader Biomedical Co Ltd ROCO:7713
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Weleader Biomedical Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of NT$-5 Mil mean?
Weleader Biomedical Co (ROCO:7713) has a Change In Inventory of NT$-5 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Weleader Biomedical Co and its competitors.
Is Weleader Biomedical Co's Change In Inventory too high?
Weleader Biomedical Co's current Change In Inventory is NT$-5 Mil. Overall, Weleader Biomedical Co has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Weleader Biomedical Co's Change In Inventory compare to ABT and SYK?
Weleader Biomedical Co's Change In Inventory of NT$-5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Medical Devices & Instruments company?
A good Change In Inventory depends on the Medical Devices & Instruments industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Weleader Biomedical Co and its competitors. Weleader Biomedical Co's current Change In Inventory is NT$-5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Weleader Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Weleader Biomedical Co (ROCO:7713) is currently considered Fairly Valued. The stock's GF Value™ is NT$74.38, compared to a current price of NT$73.90 — trading 0.6% below its estimated fair value. The current Change In Inventory is NT$-5 Mil. Weleader Biomedical Co's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Weleader Biomedical Co (ROCO:7713), the current Change In Inventory is NT$-5 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Weleader Biomedical Co (ROCO:7713) Overvalued in 2026?

Based on GuruFocus' analysis, Weleader Biomedical Co stock appears to be undervalued. The current stock price of NT$73.90 is trading 0.6% below its estimated GF Value™ of NT$74.38. GuruFocus considers Weleader Biomedical Co to be Fairly Valued.

Key valuation signals for ROCO:7713:

  • Change In Inventory: NT$-5 Mil
  • GF Value™: NT$74.38 vs. price of NT$73.90 (0.6% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the ROCO:7713 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Weleader Biomedical Co Business Description

Address No. 80, Minzu 1st Road, 19th Floor - 1 & 2, Sanmin District, Kaohsiung, TWN
Weleader Biomedical Co Ltd is mainly engages in the sales of medical testing reagents and medical devices; and the leasing of testing instruments. The reportable segments of the Group are: The Company, which includes sale of testing reagents, and provision of testing instruments and services; and Health Leader, which includes sale of dietary supplements and testing reagents, and provision of information and professional services. It derives majority revenue from the Company segment. Geographically, the company operates and generates revenue from Taiwan.
69GF Score

Get the complete analysis for ROCO:7713

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$73.90
Price
NT$74.38
GF Value